» Articles » PMID: 35614512

HIV HGM Biobank As a Research Platform for Paediatric Infectious Diseases and COVID-19 Pandemic

Overview
Journal AIDS Res Ther
Publisher Biomed Central
Date 2022 May 25
PMID 35614512
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The initial cases of COVID-19 appeared in December 2019 and Spain was one of the most affected countries during the first wave (March to June). Since then, HIV HGM BioBank has been restructured as an established Paediatrics and Adults HIV_COVID-19 BioBank that aims at the long-term storage of samples obtained from not only HIV-1, but also from COVID-19 patients and HIV-1_COVID-19 coinfected patients.

Methods: HIV HGM BioBank holds high quality biological samples from newborns, children, adolescents and adults with their associated clinical data. Research groups trying to establish large networks focused on research on specific clinical problems in epidemiology, biology, routes of transmission and therapies, are potential users of the clinical samples and of associated data of HIV-1_COVID-19 HGM BioBank.

Results: The HIV HGM BioBank is an academic and ethical enterprise complying with all the legal regulatory rules to provide service to the society. HIV_COVID-19 HGM BioBank has been repurposed to offer an important resource for global research of COVID-19 in newborns, children, adolescents, adults and elders to study the biological effect of the pandemic.

Conclusion: Herein, we present a description of how HIV HGM BioBank has rapidly become an indispensable structure in modern biomedical research, including COVID-19 research.

Citing Articles

Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients.

Bermejo-Gomez A, Tarancon-Diez L, Lazaro-Martin B, Santiago-Garcia B, Gil Villanueva N, Alonso R Heliyon. 2025; 11(1):e41584.

PMID: 39866443 PMC: 11758410. DOI: 10.1016/j.heliyon.2024.e41584.


Biobanking in times of crisis - The COVID-19 Autopsy and Biosample Registry Baden-Wuerttemberg.

Domke L, Klein I, Hartmann L, Schwab C, Marx A, Werner M Pathol Res Pract. 2022; 237:154011.

PMID: 35841694 PMC: 9250824. DOI: 10.1016/j.prp.2022.154011.

References
1.
Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

2.
Gottweis H, Zatloukal K . Biobank governance: trends and perspectives. Pathobiology. 2007; 74(4):206-11. DOI: 10.1159/000104446. View

3.
Khan K, Lustig G, Bernstein M, Archary D, Cele S, Karim F . Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV). Clin Infect Dis. 2021; 75(1):e857-e864. PMC: 8689810. DOI: 10.1093/cid/ciab1008. View

4.
Wang C, Horby P, Hayden F, Gao G . A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223):470-473. PMC: 7135038. DOI: 10.1016/S0140-6736(20)30185-9. View

5.
Garcia-Merino I, Consuegra I, Jimenez J, Munoz-Fernandez M . Specific legislation on biobanks in Spain. Biopreserv Biobank. 2015; 13(3):207-11. DOI: 10.1089/bio.2014.0070. View